Flagship's first venture of 2020 is out, and it's all about sperm
A couple years ago, Amber Salzman got a call as she was returning East full-time after a two-year stint running a gene therapy company in California.
It was from someone at Flagship Pioneering, the deep-pocketed biotech venture firm. They had a new company with a new way of thinking about sperm. It had been incubating for over a year, and now they wanted her to run it.
“It exactly fit,” Salzman told Endpoints News. “I just thought I had to do something.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.